SAN DIEGO, June 24, 2013 /PRNewswire/ -- CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today announced that 14 additional hospitals across the country have adopted the ...

To view the multimedia assets associated with this release, please visit: http://www.multivu.com/mnr/53365-carefusion-unveils-pyxis-automated-medication-dispensing ...

SAN DIEGO, Dec. 7 CareFusion (NYSE: CFN), a leading, global medical device company, today announced six new Pyxis® medication management products at the 44th American Society for Health System ...

When patients begin receiving care at St. Luke's Same Day Surgery Center in April, they'll receive medications through a computerized pharmacy system that's been in use throughout St. Luke's Regional ...

CareFusion, a global medical device company, and Cerner Corp., a global provider of healthcare solutions and services, have announced an agreement to improve data communication between CareFusion ...

Stephens has initiated coverage on Pyxis Oncology Inc (NASDAQ:PYXS), highlighting the company’s technology platform aimed at developing next-gen antibody-drug conjugates (ADCs) with enhanced potency, ...

Pyxis Oncology is aiming to close out a transformative 2021 with an IPO. Having licensed a pair of antibody-drug conjugates (ADCs) from Pfizer and raised a megaround to develop them, Pyxis is now ...

Pyxis Oncology has plenty to do with three antibody-drug conjugates in the pipeline, so the upstart biotech has formed a new joint venture called Kyma Therapeutics with Alloy Therapeutics to develop ...

CAMBRIDGE, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat ...

On Wednesday, Pyxis Oncology, Inc. (NASDAQ:PYXS) released preliminary data from the ongoing Phase 1 clinical dose escalation study evaluating PYX-201 in multiple solid tumors. Among evaluable Head and ...